Inhibitory Effect of Polyphenols (phenolic Acids, Lignans, and Stilbenes) on Cancer by Regulating Signal Transduction Pathways: a Review

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2021 Oct 5

PMID 34609675

Citations 18

Authors

A Hazafa

M O Iqbal

U Javaid

M B K Tareen

D Amna

A Ramzan

S Piracha

M Naeem

Affiliations

Soon will be listed here.

Abstract

Natural products, especially polyphenols (phenolic acids, lignans, and stilbenes) are suggested to be more potent anticancer drugs because of their no or less adverse effects, excess availability, high accuracy, and secure mode of action. In the present review, potential anticancer mechanisms of action of some polyphenols including phenolic acids, lignans, and stilbenes are discussed based on clinical, epidemiological, in vivo, and in vitro studies. The emerging evidence revealed that phenolic acids, lignans, and stilbenes induced apoptosis in the treatment of breast (MCF-7), colon (Caco-2), lung (SKLU-1), prostate (DU-145 and LNCaP), hepatocellular (hepG-2), and cervical (A-431) cancer cells, cell cycle arrest (S/G/M/G-phases) in gastric (MKN-45 and MKN-74), colorectal (HCT-116), bladder (T-24 and 5637), oral (H-400), leukemic (HL-60 and MOLT-4) and colon (Caco-2) cancer cells, and inhibit cell proliferation against the prostate (PC-3), liver (LI-90), breast (T47D and MDA-MB-231), colon (HT-29 and Caco-2), cervical (HTB-35), and MIC-1 cancer cells through caspase-3, MAPK, AMPK, Akt, NF-κB, Wnt, CD95, and SIRT1 pathways. Based on accumulated data, we suggested that polyphenols could be considered as a viable therapeutic option in the treatment of cancer cells in the near future.

Citing Articles

Stilbene Treatment Reduces Stemness Features in Human Lung Adenocarcinoma Model.

Livraghi V, Grossi A, Scopelliti A, Senise G, Gamboa L, Solito S Int J Mol Sci. 2024; 25(19).

PMID: 39408719 PMC: 11476666. DOI: 10.3390/ijms251910390.

A proteasome-dependent inhibition of SIRT-1 by the resveratrol analogue 4,4'-dihydroxy-stilbene.

Livraghi V, Mazza L, Chiappori F, Cardano M, Cazzalini O, Puglisi R J Tradit Complement Med. 2024; 14(5):534-543.

PMID: 39262665 PMC: 11384077. DOI: 10.1016/j.jtcme.2024.03.001.

Construction and Identification of Eukaryotic Expression Vector pEGFP-N1-MIC-1 for Mouse MIC-1 Gene and Its Effect on Gastric Cancer Cells.

Zhang H, Qin Z, Shi S, Li Y, Song Y, Zhang Y Anal Cell Pathol (Amst). 2024; 2024:2165242.

PMID: 39045215 PMC: 11265941. DOI: 10.1155/2024/2165242.

Phenolic acids from medicinal and edible homologous plants: a potential anti-inflammatory agent for inflammatory diseases.

Xie J, Xiong S, Li Y, Xia B, Li M, Zhang Z Front Immunol. 2024; 15:1345002.

PMID: 38975345 PMC: 11224438. DOI: 10.3389/fimmu.2024.1345002.

Garden cress seeds: a review on nutritional composition, therapeutic potential, and industrial utilization.

Tufail T, Khan T, Ul Ain H, Morya S, Shah M Food Sci Nutr. 2024; 12(6):3834-3848.

PMID: 38873486 PMC: 11167195. DOI: 10.1002/fsn3.4096.

References

Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S . Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016; 4(9):e609-16. DOI: 10.1016/S2214-109X(16)30143-7. View

Cragg G, Newman D . Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005; 100(1-2):72-9. DOI: 10.1016/j.jep.2005.05.011. View

Rayan A, Raiyn J, Falah M . Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. PLoS One. 2017; 12(11):e0187925. PMC: 5679595. DOI: 10.1371/journal.pone.0187925. View

Manach C, Scalbert A, Morand C, Remesy C, Jimenez L . Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004; 79(5):727-47. DOI: 10.1093/ajcn/79.5.727. View

Hazafa A, Rehman K, Jahan N, Jabeen Z . The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells. Nutr Cancer. 2019; 72(3):386-397. DOI: 10.1080/01635581.2019.1637006. View

Zamora-Ros R, Not C, Guino E, Lujan-Barroso L, Garcia R, Biondo S . Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). Cancer Causes Control. 2012; 24(3):549-57. DOI: 10.1007/s10552-012-9992-z. View

Xie Q, Chen M, Qin Y, Zhang Q, Xu H, Zhou Y . Isoflavone consumption and risk of breast cancer: a dose-response meta-analysis of observational studies. Asia Pac J Clin Nutr. 2013; 22(1):118-27. DOI: 10.6133/apjcn.2013.22.1.16. View

Chen M, Rao Y, Zheng Y, Wei S, Li Y, Guo T . Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies. PLoS One. 2014; 9(2):e89288. PMC: 3930722. DOI: 10.1371/journal.pone.0089288. View

McCann S, Thompson L, Nie J, Dorn J, Trevisan M, Shields P . Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2009; 122(1):229-35. PMC: 2883619. DOI: 10.1007/s10549-009-0681-x. View

10.

Scalbert A, Johnson I, Saltmarsh M . Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005; 81(1 Suppl):215S-217S. DOI: 10.1093/ajcn/81.1.215S. View

11.

Fantini M, Benvenuto M, Masuelli L, Frajese G, Tresoldi I, Modesti A . In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci. 2015; 16(5):9236-82. PMC: 4463587. DOI: 10.3390/ijms16059236. View

12.

Spilioti E, Jaakkola M, Tolonen T, Lipponen M, Virtanen V, Chinou I . Phenolic acid composition, antiatherogenic and anticancer potential of honeys derived from various regions in Greece. PLoS One. 2014; 9(4):e94860. PMC: 3994057. DOI: 10.1371/journal.pone.0094860. View

13.

Ho M, Chen P, Chu S, Kuo D, Kuo W, Chen J . Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway. Nutr Cancer. 2010; 62(4):505-16. DOI: 10.1080/01635580903441261. View

14.

Subramanian A, Jaganathan S, Mandal M, Supriyanto E, Muhamad I . Gallic acid induced apoptotic events in HCT-15 colon cancer cells. World J Gastroenterol. 2016; 22(15):3952-61. PMC: 4823245. DOI: 10.3748/wjg.v22.i15.3952. View

15.

Russell Jr L, Mazzio E, Badisa R, Zhu Z, Agharahimi M, Oriaku E . Autoxidation of gallic acid induces ROS-dependent death in human prostate cancer LNCaP cells. Anticancer Res. 2012; 32(5):1595-602. PMC: 3356927. View

16.

Liu K, Huang A, Wu P, Lin H, Chueh F, Yang J . Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. Oncol Rep. 2011; 26(1):177-84. DOI: 10.3892/or.2011.1264. View

17.

Zhao B, Hu M . Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells. Oncol Lett. 2014; 6(6):1749-1755. PMC: 4023842. DOI: 10.3892/ol.2013.1632. View

18.

Forester S, Choy Y, Waterhouse A, Oteiza P . The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals. Mol Carcinog. 2012; 53(6):432-9. DOI: 10.1002/mc.21974. View

19.

Coman V, Vodnar D . Hydroxycinnamic acids and human health: recent advances. J Sci Food Agric. 2019; 100(2):483-499. DOI: 10.1002/jsfa.10010. View

20.

Lin V, Tsai Y, Lin J, Fan L, Pan M, Ho C . Activation of AMPK by pterostilbene suppresses lipogenesis and cell-cycle progression in p53 positive and negative human prostate cancer cells. J Agric Food Chem. 2012; 60(25):6399-407. DOI: 10.1021/jf301499e. View